New report warns repeat prescription system strains NHS and patients
A fresh study highlights that the UK’s repeat-prescription process is costly for both the NHS and patients, despite digital advances.
The Repeat Prescription Report, published today, warns that one outlet repeat-prescription workflow imposes a growing financial strain on the NHS, which allocates around £9 billion annually to repeat medicines, including £1.5 billion for diabetes treatments. Patients on repeat prescriptions spend an average of 1 hour 36 minutes each month picking up drugs and pay about £6.50 in travel expenses, creating an estimated £11.5 billion economic cost nationwide.
More than half of users reported needing a second pharmacy trip because prescriptions were not ready, while a quarter left due to long queues, and one-third missed receiving medication because of errors. The study, authored by Imperial College London’s Waseem Jerjes and Austen El-Osta, notes that 97 % of prescriptions are now sent electronically, yet the delivery of medicines has not kept pace. It recommends improving real-time updates, expanding awareness of online and community pharmacy options, and using repeat prescribing as a preventive health touchpoint. Phil Day of Pharmacy2U stresses that rising demand from an aging population will intensify pressure on GPs and pharmacies unless the system is streamlined.
Why it matters
The findings show how inefficient repeat-prescription handling wastes time, money and health resources for patients and the NHS.
In this story
